nodes	percent_of_prediction	percent_of_DWPC	metapath
Felodipine—ABCB1—hematologic cancer	0.0482	1	CbGaD
Felodipine—NR3C2—Betamethasone—hematologic cancer	0.0444	0.0821	CbGbCtD
Felodipine—NR3C2—Prednisolone—hematologic cancer	0.0438	0.081	CbGbCtD
Felodipine—NR3C2—Dexamethasone—hematologic cancer	0.0258	0.0478	CbGbCtD
Felodipine—CYP2C9—Bexarotene—hematologic cancer	0.0111	0.0205	CbGbCtD
Felodipine—ABCB1—Lenalidomide—hematologic cancer	0.0107	0.0199	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0103	0.0191	CbGbCtD
Felodipine—CYP3A7—Ifosfamide—hematologic cancer	0.0103	0.0191	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00988	0.0183	CbGbCtD
Felodipine—CYP3A7—Imatinib—hematologic cancer	0.00988	0.0183	CbGbCtD
Felodipine—CYP2C8—Bortezomib—hematologic cancer	0.00973	0.018	CbGbCtD
Felodipine—CYP3A5—Daunorubicin—hematologic cancer	0.00968	0.0179	CbGbCtD
Felodipine—CYP2D6—Lomustine—hematologic cancer	0.00941	0.0174	CbGbCtD
Felodipine—CYP2C9—Idarubicin—hematologic cancer	0.00917	0.017	CbGbCtD
Felodipine—CYP3A5—Thalidomide—hematologic cancer	0.00882	0.0163	CbGbCtD
Felodipine—CYP3A5—Teniposide—hematologic cancer	0.00841	0.0155	CbGbCtD
Felodipine—CYP2D6—Idarubicin—hematologic cancer	0.00839	0.0155	CbGbCtD
Felodipine—CYP3A5—Ifosfamide—hematologic cancer	0.00776	0.0143	CbGbCtD
Felodipine—CYP2C8—Ifosfamide—hematologic cancer	0.00746	0.0138	CbGbCtD
Felodipine—CYP3A5—Imatinib—hematologic cancer	0.00741	0.0137	CbGbCtD
Felodipine—CYP2D6—Hydroxyurea—hematologic cancer	0.00713	0.0132	CbGbCtD
Felodipine—CYP2C9—Bortezomib—hematologic cancer	0.00679	0.0125	CbGbCtD
Felodipine—CYP2C8—Nilotinib—hematologic cancer	0.00648	0.012	CbGbCtD
Felodipine—CYP3A4—Bexarotene—hematologic cancer	0.00644	0.0119	CbGbCtD
Felodipine—ABCB1—Daunorubicin—hematologic cancer	0.0063	0.0116	CbGbCtD
Felodipine—CYP2D6—Bortezomib—hematologic cancer	0.00621	0.0115	CbGbCtD
Felodipine—CYP3A7—Irinotecan—hematologic cancer	0.00617	0.0114	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00617	0.0114	CbGbCtD
Felodipine—ABCB1—Alitretinoin—hematologic cancer	0.00617	0.0114	CbGbCtD
Felodipine—CYP3A4—Lomustine—hematologic cancer	0.00599	0.0111	CbGbCtD
Felodipine—CYP3A4—Busulfan—hematologic cancer	0.00599	0.0111	CbGbCtD
Felodipine—CYP3A5—Dasatinib—hematologic cancer	0.00595	0.011	CbGbCtD
Felodipine—CYP2C9—Thalidomide—hematologic cancer	0.00591	0.0109	CbGbCtD
Felodipine—CYP2C9—Teniposide—hematologic cancer	0.00564	0.0104	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.0054	0.00997	CbGbCtD
Felodipine—CYP3A7—Vincristine—hematologic cancer	0.0054	0.00997	CbGbCtD
Felodipine—CYP3A4—Thiotepa—hematologic cancer	0.00533	0.00986	CbGbCtD
Felodipine—CYP2C9—Ifosfamide—hematologic cancer	0.00521	0.00962	CbGbCtD
Felodipine—CYP2C9—Imatinib—hematologic cancer	0.00497	0.00919	CbGbCtD
Felodipine—ABCB1—Imatinib—hematologic cancer	0.00483	0.00892	CbGbCtD
Felodipine—CYP3A5—Irinotecan—hematologic cancer	0.00463	0.00856	CbGbCtD
Felodipine—CYP2D6—Imatinib—hematologic cancer	0.00455	0.0084	CbGbCtD
Felodipine—CYP2C9—Nilotinib—hematologic cancer	0.00452	0.00835	CbGbCtD
Felodipine—ABCB1—Nilotinib—hematologic cancer	0.00439	0.00811	CbGbCtD
Felodipine—ABCB1—Vinorelbine—hematologic cancer	0.00435	0.00804	CbGbCtD
Felodipine—CYP3A4—Methoxsalen—hematologic cancer	0.00415	0.00767	CbGbCtD
Felodipine—CYP2D6—Nilotinib—hematologic cancer	0.00413	0.00764	CbGbCtD
Felodipine—CYP2D6—Vinorelbine—hematologic cancer	0.0041	0.00757	CbGbCtD
Felodipine—CYP3A7—Dexamethasone—hematologic cancer	0.00407	0.00752	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00407	0.00752	CbGbCtD
Felodipine—CYP3A5—Vincristine—hematologic cancer	0.00405	0.00748	CbGbCtD
Felodipine—CYP3A4—Bortezomib—hematologic cancer	0.00395	0.00729	CbGbCtD
Felodipine—ABCB1—Dasatinib—hematologic cancer	0.00388	0.00716	CbGbCtD
Felodipine—ABCB1—Mitoxantrone—hematologic cancer	0.00383	0.00708	CbGbCtD
Felodipine—CYP3A4—Daunorubicin—hematologic cancer	0.00377	0.00698	CbGbCtD
Felodipine—CYP3A5—Etoposide—hematologic cancer	0.00371	0.00686	CbGbCtD
Felodipine—CYP2C8—Etoposide—hematologic cancer	0.00357	0.00659	CbGbCtD
Felodipine—ABCB1—Betamethasone—hematologic cancer	0.00341	0.00631	CbGbCtD
Felodipine—ABCB1—Gemcitabine—hematologic cancer	0.00338	0.00625	CbGbCtD
Felodipine—ABCB1—Prednisolone—hematologic cancer	0.00337	0.00622	CbGbCtD
Felodipine—CYP3A4—Cytarabine—hematologic cancer	0.00333	0.00615	CbGbCtD
Felodipine—CYP3A4—Teniposide—hematologic cancer	0.00328	0.00606	CbGbCtD
Felodipine—ABCB1—Prednisone—hematologic cancer	0.00318	0.00588	CbGbCtD
Felodipine—CYP3A5—Dexamethasone—hematologic cancer	0.00305	0.00564	CbGbCtD
Felodipine—CYP3A4—Ifosfamide—hematologic cancer	0.00303	0.00559	CbGbCtD
Felodipine—ABCB1—Irinotecan—hematologic cancer	0.00301	0.00557	CbGbCtD
Felodipine—CYP2C8—Dexamethasone—hematologic cancer	0.00293	0.00542	CbGbCtD
Felodipine—CYP3A4—Imatinib—hematologic cancer	0.00289	0.00534	CbGbCtD
Felodipine—CYP3A4—Ruxolitinib—hematologic cancer	0.00272	0.00503	CbGbCtD
Felodipine—ABCB1—Vinblastine—hematologic cancer	0.00268	0.00495	CbGbCtD
Felodipine—ABCB1—Vincristine—hematologic cancer	0.00263	0.00487	CbGbCtD
Felodipine—CYP3A4—Nilotinib—hematologic cancer	0.00263	0.00486	CbGbCtD
Felodipine—CYP3A4—Vinorelbine—hematologic cancer	0.00261	0.00482	CbGbCtD
Felodipine—CYP2C9—Cisplatin—hematologic cancer	0.00253	0.00468	CbGbCtD
Felodipine—CYP2D6—Vinblastine—hematologic cancer	0.00252	0.00467	CbGbCtD
Felodipine—ABCB1—Cisplatin—hematologic cancer	0.00246	0.00454	CbGbCtD
Felodipine—ABCB1—Etoposide—hematologic cancer	0.00241	0.00446	CbGbCtD
Felodipine—TNNC2—testis—hematologic cancer	0.00239	0.0439	CbGeAlD
Felodipine—CYP3A4—Triamcinolone—hematologic cancer	0.00238	0.0044	CbGbCtD
Felodipine—CYP3A4—Dasatinib—hematologic cancer	0.00232	0.00429	CbGbCtD
Felodipine—CYP3A4—Mitoxantrone—hematologic cancer	0.00229	0.00424	CbGbCtD
Felodipine—TNNC1—hematopoietic system—hematologic cancer	0.00219	0.0404	CbGeAlD
Felodipine—CYP2C9—Dexamethasone—hematologic cancer	0.00205	0.00378	CbGbCtD
Felodipine—CYP3A4—Betamethasone—hematologic cancer	0.00204	0.00378	CbGbCtD
Felodipine—CYP3A4—Prednisolone—hematologic cancer	0.00202	0.00373	CbGbCtD
Felodipine—ABCB1—Dexamethasone—hematologic cancer	0.00198	0.00367	CbGbCtD
Felodipine—CYP3A4—Prednisone—hematologic cancer	0.0019	0.00352	CbGbCtD
Felodipine—CYP2D6—Dexamethasone—hematologic cancer	0.00187	0.00346	CbGbCtD
Felodipine—CYP3A4—Irinotecan—hematologic cancer	0.00181	0.00334	CbGbCtD
Felodipine—PDE1B—gonad—hematologic cancer	0.00174	0.032	CbGeAlD
Felodipine—TNNC2—lymph node—hematologic cancer	0.00173	0.0318	CbGeAlD
Felodipine—ABCB1—Doxorubicin—hematologic cancer	0.00165	0.00304	CbGbCtD
Felodipine—CYP3A4—Vinblastine—hematologic cancer	0.00161	0.00297	CbGbCtD
Felodipine—ABCB1—Methotrexate—hematologic cancer	0.0016	0.00295	CbGbCtD
Felodipine—CYP3A4—Vincristine—hematologic cancer	0.00158	0.00292	CbGbCtD
Felodipine—CYP2D6—Doxorubicin—hematologic cancer	0.00155	0.00287	CbGbCtD
Felodipine—PDE1B—blood—hematologic cancer	0.00152	0.0279	CbGeAlD
Felodipine—PDE1A—gonad—hematologic cancer	0.00146	0.0268	CbGeAlD
Felodipine—TNNC1—blood—hematologic cancer	0.00145	0.0267	CbGeAlD
Felodipine—CYP3A4—Etoposide—hematologic cancer	0.00145	0.00267	CbGbCtD
Felodipine—TNNC1—lung—hematologic cancer	0.00127	0.0234	CbGeAlD
Felodipine—PDE1B—testis—hematologic cancer	0.00125	0.0231	CbGeAlD
Felodipine—TNNC1—testis—hematologic cancer	0.0012	0.0221	CbGeAlD
Felodipine—CYP3A4—Dexamethasone—hematologic cancer	0.00119	0.0022	CbGbCtD
Felodipine—CACNA1H—gonad—hematologic cancer	0.00114	0.0209	CbGeAlD
Felodipine—PDE1A—lung—hematologic cancer	0.00111	0.0205	CbGeAlD
Felodipine—CACNA2D2—lung—hematologic cancer	0.00107	0.0197	CbGeAlD
Felodipine—PDE1A—testis—hematologic cancer	0.00105	0.0193	CbGeAlD
Felodipine—NR3C2—hematopoietic system—hematologic cancer	0.00104	0.0191	CbGeAlD
Felodipine—CACNA2D2—testis—hematologic cancer	0.00101	0.0186	CbGeAlD
Felodipine—CYP3A4—Doxorubicin—hematologic cancer	0.000987	0.00182	CbGbCtD
Felodipine—PDE1B—lymph node—hematologic cancer	0.000909	0.0167	CbGeAlD
Felodipine—TNNC1—lymph node—hematologic cancer	0.000871	0.016	CbGeAlD
Felodipine—CACNA2D1—bone marrow—hematologic cancer	0.000851	0.0157	CbGeAlD
Felodipine—CACNB2—lung—hematologic cancer	0.000821	0.0151	CbGeAlD
Felodipine—CACNA1H—testis—hematologic cancer	0.00082	0.0151	CbGeAlD
Felodipine—CACNB2—testis—hematologic cancer	0.000775	0.0143	CbGeAlD
Felodipine—CACNA2D1—lung—hematologic cancer	0.000771	0.0142	CbGeAlD
Felodipine—PDE1A—lymph node—hematologic cancer	0.000762	0.014	CbGeAlD
Felodipine—CALM2—hematopoietic system—hematologic cancer	0.00075	0.0138	CbGeAlD
Felodipine—CALM1—hematopoietic system—hematologic cancer	0.000747	0.0137	CbGeAlD
Felodipine—CACNA2D2—lymph node—hematologic cancer	0.000733	0.0135	CbGeAlD
Felodipine—CACNA2D1—testis—hematologic cancer	0.000727	0.0134	CbGeAlD
Felodipine—CACNA1D—lung—hematologic cancer	0.000718	0.0132	CbGeAlD
Felodipine—NR3C2—blood—hematologic cancer	0.000688	0.0127	CbGeAlD
Felodipine—CACNA1D—testis—hematologic cancer	0.000677	0.0125	CbGeAlD
Felodipine—CACNA1C—lung—hematologic cancer	0.000662	0.0122	CbGeAlD
Felodipine—CALM3—blood—hematologic cancer	0.000633	0.0116	CbGeAlD
Felodipine—CACNA1C—testis—hematologic cancer	0.000625	0.0115	CbGeAlD
Felodipine—CYP2C8—hematopoietic system—hematologic cancer	0.000622	0.0114	CbGeAlD
Felodipine—CALM3—bone marrow—hematologic cancer	0.000612	0.0113	CbGeAlD
Felodipine—NR3C2—lung—hematologic cancer	0.000603	0.0111	CbGeAlD
Felodipine—CACNA1H—lymph node—hematologic cancer	0.000595	0.0109	CbGeAlD
Felodipine—CALM2—gonad—hematologic cancer	0.00057	0.0105	CbGeAlD
Felodipine—NR3C2—testis—hematologic cancer	0.000569	0.0105	CbGeAlD
Felodipine—CALM1—gonad—hematologic cancer	0.000568	0.0104	CbGeAlD
Felodipine—CACNB2—lymph node—hematologic cancer	0.000561	0.0103	CbGeAlD
Felodipine—CYP3A5—hematopoietic system—hematologic cancer	0.000561	0.0103	CbGeAlD
Felodipine—CALM3—lung—hematologic cancer	0.000555	0.0102	CbGeAlD
Felodipine—CYP2C9—hematopoietic system—hematologic cancer	0.000552	0.0102	CbGeAlD
Felodipine—CACNA2D1—lymph node—hematologic cancer	0.000527	0.0097	CbGeAlD
Felodipine—CALM3—testis—hematologic cancer	0.000523	0.00963	CbGeAlD
Felodipine—CALM2—blood—hematologic cancer	0.000497	0.00914	CbGeAlD
Felodipine—CALM1—blood—hematologic cancer	0.000495	0.0091	CbGeAlD
Felodipine—CACNA1D—lymph node—hematologic cancer	0.000491	0.00903	CbGeAlD
Felodipine—CALM2—bone marrow—hematologic cancer	0.000481	0.00885	CbGeAlD
Felodipine—CALM1—bone marrow—hematologic cancer	0.000479	0.00881	CbGeAlD
Felodipine—CACNA1C—lymph node—hematologic cancer	0.000453	0.00833	CbGeAlD
Felodipine—CALM2—lung—hematologic cancer	0.000436	0.00802	CbGeAlD
Felodipine—CALM1—lung—hematologic cancer	0.000434	0.00798	CbGeAlD
Felodipine—CYP3A4—hematopoietic system—hematologic cancer	0.000421	0.00775	CbGeAlD
Felodipine—CYP2D6—hematopoietic system—hematologic cancer	0.000414	0.00762	CbGeAlD
Felodipine—NR3C2—lymph node—hematologic cancer	0.000412	0.00759	CbGeAlD
Felodipine—CYP2C8—blood—hematologic cancer	0.000412	0.00758	CbGeAlD
Felodipine—CALM2—testis—hematologic cancer	0.000411	0.00756	CbGeAlD
Felodipine—CALM1—testis—hematologic cancer	0.000409	0.00753	CbGeAlD
Felodipine—CALM3—lymph node—hematologic cancer	0.000379	0.00698	CbGeAlD
Felodipine—CYP3A5—blood—hematologic cancer	0.000372	0.00684	CbGeAlD
Felodipine—CYP2C9—blood—hematologic cancer	0.000366	0.00673	CbGeAlD
Felodipine—CYP2C8—testis—hematologic cancer	0.000341	0.00627	CbGeAlD
Felodipine—CYP3A5—lung—hematologic cancer	0.000326	0.006	CbGeAlD
Felodipine—ABCB1—hematopoietic system—hematologic cancer	0.000298	0.00548	CbGeAlD
Felodipine—CALM2—lymph node—hematologic cancer	0.000298	0.00548	CbGeAlD
Felodipine—CALM1—lymph node—hematologic cancer	0.000297	0.00546	CbGeAlD
Felodipine—Nifedipine—ABCC3—hematologic cancer	0.000283	0.461	CrCbGaD
Felodipine—CYP3A4—blood—hematologic cancer	0.000279	0.00513	CbGeAlD
Felodipine—CYP2D6—blood—hematologic cancer	0.000275	0.00505	CbGeAlD
Felodipine—CYP2D6—testis—hematologic cancer	0.000227	0.00418	CbGeAlD
Felodipine—ABCB1—gonad—hematologic cancer	0.000227	0.00417	CbGeAlD
Felodipine—ABCB1—blood—hematologic cancer	0.000197	0.00363	CbGeAlD
Felodipine—ABCB1—bone marrow—hematologic cancer	0.000191	0.00352	CbGeAlD
Felodipine—ABCB1—lung—hematologic cancer	0.000173	0.00319	CbGeAlD
Felodipine—ABCB1—testis—hematologic cancer	0.000163	0.00301	CbGeAlD
Felodipine—ABCB1—lymph node—hematologic cancer	0.000118	0.00218	CbGeAlD
Felodipine—Nisoldipine—ABCB1—hematologic cancer	7.94e-05	0.129	CrCbGaD
Felodipine—Nitrendipine—ABCB1—hematologic cancer	7.43e-05	0.121	CrCbGaD
Felodipine—Amlodipine—ABCB1—hematologic cancer	6.4e-05	0.104	CrCbGaD
Felodipine—Nifedipine—ABCB1—hematologic cancer	5.72e-05	0.0931	CrCbGaD
Felodipine—Nicardipine—ABCB1—hematologic cancer	5.63e-05	0.0917	CrCbGaD
Felodipine—Pharyngitis—Epirubicin—hematologic cancer	3.99e-05	0.000209	CcSEcCtD
Felodipine—Fatigue—Triamcinolone—hematologic cancer	3.99e-05	0.000209	CcSEcCtD
Felodipine—Rash—Vincristine—hematologic cancer	3.97e-05	0.000208	CcSEcCtD
Felodipine—Dermatitis—Vincristine—hematologic cancer	3.96e-05	0.000208	CcSEcCtD
Felodipine—Oedema peripheral—Epirubicin—hematologic cancer	3.96e-05	0.000207	CcSEcCtD
Felodipine—Headache—Vincristine—hematologic cancer	3.94e-05	0.000206	CcSEcCtD
Felodipine—Loss of consciousness—Prednisone—hematologic cancer	3.94e-05	0.000206	CcSEcCtD
Felodipine—Nausea—Carmustine—hematologic cancer	3.92e-05	0.000205	CcSEcCtD
Felodipine—Epistaxis—Doxorubicin—hematologic cancer	3.91e-05	0.000205	CcSEcCtD
Felodipine—Vomiting—Irinotecan—hematologic cancer	3.9e-05	0.000204	CcSEcCtD
Felodipine—Vomiting—Mitoxantrone—hematologic cancer	3.9e-05	0.000204	CcSEcCtD
Felodipine—Sinusitis—Doxorubicin—hematologic cancer	3.89e-05	0.000204	CcSEcCtD
Felodipine—Nausea—Alitretinoin—hematologic cancer	3.88e-05	0.000203	CcSEcCtD
Felodipine—Visual impairment—Epirubicin—hematologic cancer	3.88e-05	0.000203	CcSEcCtD
Felodipine—Rash—Mitoxantrone—hematologic cancer	3.86e-05	0.000202	CcSEcCtD
Felodipine—Rash—Irinotecan—hematologic cancer	3.86e-05	0.000202	CcSEcCtD
Felodipine—Dermatitis—Irinotecan—hematologic cancer	3.86e-05	0.000202	CcSEcCtD
Felodipine—Dermatitis—Mitoxantrone—hematologic cancer	3.86e-05	0.000202	CcSEcCtD
Felodipine—Headache—Mitoxantrone—hematologic cancer	3.84e-05	0.000201	CcSEcCtD
Felodipine—Headache—Irinotecan—hematologic cancer	3.84e-05	0.000201	CcSEcCtD
Felodipine—Nausea—Ifosfamide—hematologic cancer	3.83e-05	0.000201	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.82e-05	0.0002	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.82e-05	0.0002	CcSEcCtD
Felodipine—Arthralgia—Prednisone—hematologic cancer	3.81e-05	0.0002	CcSEcCtD
Felodipine—Myalgia—Prednisone—hematologic cancer	3.81e-05	0.0002	CcSEcCtD
Felodipine—Feeling abnormal—Triamcinolone—hematologic cancer	3.81e-05	0.000199	CcSEcCtD
Felodipine—Diarrhoea—Cisplatin—hematologic cancer	3.81e-05	0.000199	CcSEcCtD
Felodipine—Erythema multiforme—Epirubicin—hematologic cancer	3.8e-05	0.000199	CcSEcCtD
Felodipine—Vomiting—Gemcitabine—hematologic cancer	3.8e-05	0.000199	CcSEcCtD
Felodipine—Insomnia—Dexamethasone—hematologic cancer	3.8e-05	0.000199	CcSEcCtD
Felodipine—Insomnia—Betamethasone—hematologic cancer	3.8e-05	0.000199	CcSEcCtD
Felodipine—Bradycardia—Doxorubicin—hematologic cancer	3.79e-05	0.000198	CcSEcCtD
Felodipine—Paraesthesia—Dexamethasone—hematologic cancer	3.77e-05	0.000197	CcSEcCtD
Felodipine—Paraesthesia—Betamethasone—hematologic cancer	3.77e-05	0.000197	CcSEcCtD
Felodipine—Rash—Gemcitabine—hematologic cancer	3.76e-05	0.000197	CcSEcCtD
Felodipine—Dermatitis—Gemcitabine—hematologic cancer	3.76e-05	0.000197	CcSEcCtD
Felodipine—Hypersensitivity—Etoposide—hematologic cancer	3.76e-05	0.000197	CcSEcCtD
Felodipine—Erythema—Methotrexate—hematologic cancer	3.74e-05	0.000196	CcSEcCtD
Felodipine—Headache—Gemcitabine—hematologic cancer	3.74e-05	0.000196	CcSEcCtD
Felodipine—Nausea—Vincristine—hematologic cancer	3.74e-05	0.000196	CcSEcCtD
Felodipine—Flushing—Epirubicin—hematologic cancer	3.73e-05	0.000195	CcSEcCtD
Felodipine—Hypersensitivity—Prednisolone—hematologic cancer	3.7e-05	0.000194	CcSEcCtD
Felodipine—Pharyngitis—Doxorubicin—hematologic cancer	3.69e-05	0.000193	CcSEcCtD
Felodipine—Dyspepsia—Dexamethasone—hematologic cancer	3.69e-05	0.000193	CcSEcCtD
Felodipine—Dyspepsia—Betamethasone—hematologic cancer	3.69e-05	0.000193	CcSEcCtD
Felodipine—Urticaria—Triamcinolone—hematologic cancer	3.67e-05	0.000192	CcSEcCtD
Felodipine—Oedema peripheral—Doxorubicin—hematologic cancer	3.67e-05	0.000192	CcSEcCtD
Felodipine—Asthenia—Etoposide—hematologic cancer	3.66e-05	0.000191	CcSEcCtD
Felodipine—Body temperature increased—Triamcinolone—hematologic cancer	3.66e-05	0.000191	CcSEcCtD
Felodipine—Nausea—Irinotecan—hematologic cancer	3.64e-05	0.000191	CcSEcCtD
Felodipine—Nausea—Mitoxantrone—hematologic cancer	3.64e-05	0.000191	CcSEcCtD
Felodipine—Back pain—Methotrexate—hematologic cancer	3.62e-05	0.000189	CcSEcCtD
Felodipine—Fatigue—Betamethasone—hematologic cancer	3.62e-05	0.000189	CcSEcCtD
Felodipine—Fatigue—Dexamethasone—hematologic cancer	3.62e-05	0.000189	CcSEcCtD
Felodipine—Pruritus—Etoposide—hematologic cancer	3.61e-05	0.000189	CcSEcCtD
Felodipine—Shock—Prednisone—hematologic cancer	3.6e-05	0.000188	CcSEcCtD
Felodipine—Arrhythmia—Epirubicin—hematologic cancer	3.59e-05	0.000188	CcSEcCtD
Felodipine—Visual impairment—Doxorubicin—hematologic cancer	3.59e-05	0.000188	CcSEcCtD
Felodipine—Tachycardia—Prednisone—hematologic cancer	3.57e-05	0.000187	CcSEcCtD
Felodipine—Nausea—Gemcitabine—hematologic cancer	3.55e-05	0.000186	CcSEcCtD
Felodipine—Vomiting—Cisplatin—hematologic cancer	3.54e-05	0.000185	CcSEcCtD
Felodipine—Erythema multiforme—Doxorubicin—hematologic cancer	3.52e-05	0.000184	CcSEcCtD
Felodipine—Rash—Cisplatin—hematologic cancer	3.51e-05	0.000184	CcSEcCtD
Felodipine—Dermatitis—Cisplatin—hematologic cancer	3.51e-05	0.000184	CcSEcCtD
Felodipine—Erythema—Epirubicin—hematologic cancer	3.5e-05	0.000183	CcSEcCtD
Felodipine—Diarrhoea—Etoposide—hematologic cancer	3.49e-05	0.000183	CcSEcCtD
Felodipine—Anaemia—Methotrexate—hematologic cancer	3.46e-05	0.000181	CcSEcCtD
Felodipine—Feeling abnormal—Betamethasone—hematologic cancer	3.46e-05	0.000181	CcSEcCtD
Felodipine—Feeling abnormal—Dexamethasone—hematologic cancer	3.46e-05	0.000181	CcSEcCtD
Felodipine—Flushing—Doxorubicin—hematologic cancer	3.45e-05	0.000181	CcSEcCtD
Felodipine—Flatulence—Epirubicin—hematologic cancer	3.45e-05	0.000181	CcSEcCtD
Felodipine—Tension—Epirubicin—hematologic cancer	3.44e-05	0.00018	CcSEcCtD
Felodipine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.43e-05	0.00018	CcSEcCtD
Felodipine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.43e-05	0.00018	CcSEcCtD
Felodipine—Hypersensitivity—Triamcinolone—hematologic cancer	3.41e-05	0.000178	CcSEcCtD
Felodipine—Nervousness—Epirubicin—hematologic cancer	3.4e-05	0.000178	CcSEcCtD
Felodipine—Back pain—Epirubicin—hematologic cancer	3.39e-05	0.000177	CcSEcCtD
Felodipine—Dizziness—Etoposide—hematologic cancer	3.37e-05	0.000176	CcSEcCtD
Felodipine—Muscle spasms—Epirubicin—hematologic cancer	3.37e-05	0.000176	CcSEcCtD
Felodipine—Vertigo—Methotrexate—hematologic cancer	3.36e-05	0.000176	CcSEcCtD
Felodipine—Urticaria—Dexamethasone—hematologic cancer	3.33e-05	0.000174	CcSEcCtD
Felodipine—Urticaria—Betamethasone—hematologic cancer	3.33e-05	0.000174	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.33e-05	0.000174	CcSEcCtD
Felodipine—Dizziness—Prednisolone—hematologic cancer	3.33e-05	0.000174	CcSEcCtD
Felodipine—Arrhythmia—Doxorubicin—hematologic cancer	3.33e-05	0.000174	CcSEcCtD
Felodipine—Asthenia—Triamcinolone—hematologic cancer	3.32e-05	0.000174	CcSEcCtD
Felodipine—Body temperature increased—Dexamethasone—hematologic cancer	3.32e-05	0.000174	CcSEcCtD
Felodipine—Abdominal pain—Betamethasone—hematologic cancer	3.32e-05	0.000174	CcSEcCtD
Felodipine—Abdominal pain—Dexamethasone—hematologic cancer	3.32e-05	0.000174	CcSEcCtD
Felodipine—Body temperature increased—Betamethasone—hematologic cancer	3.32e-05	0.000174	CcSEcCtD
Felodipine—Nausea—Cisplatin—hematologic cancer	3.31e-05	0.000173	CcSEcCtD
Felodipine—Insomnia—Prednisone—hematologic cancer	3.31e-05	0.000173	CcSEcCtD
Felodipine—Paraesthesia—Prednisone—hematologic cancer	3.28e-05	0.000172	CcSEcCtD
Felodipine—Pruritus—Triamcinolone—hematologic cancer	3.27e-05	0.000171	CcSEcCtD
Felodipine—Cough—Methotrexate—hematologic cancer	3.27e-05	0.000171	CcSEcCtD
Felodipine—Vomiting—Etoposide—hematologic cancer	3.24e-05	0.00017	CcSEcCtD
Felodipine—Erythema—Doxorubicin—hematologic cancer	3.24e-05	0.00017	CcSEcCtD
Felodipine—Anaemia—Epirubicin—hematologic cancer	3.24e-05	0.000169	CcSEcCtD
Felodipine—Dyspepsia—Prednisone—hematologic cancer	3.22e-05	0.000168	CcSEcCtD
Felodipine—Rash—Etoposide—hematologic cancer	3.21e-05	0.000168	CcSEcCtD
Felodipine—Dermatitis—Etoposide—hematologic cancer	3.21e-05	0.000168	CcSEcCtD
Felodipine—Headache—Etoposide—hematologic cancer	3.19e-05	0.000167	CcSEcCtD
Felodipine—Flatulence—Doxorubicin—hematologic cancer	3.19e-05	0.000167	CcSEcCtD
Felodipine—Chest pain—Methotrexate—hematologic cancer	3.19e-05	0.000167	CcSEcCtD
Felodipine—Arthralgia—Methotrexate—hematologic cancer	3.19e-05	0.000167	CcSEcCtD
Felodipine—Myalgia—Methotrexate—hematologic cancer	3.19e-05	0.000167	CcSEcCtD
Felodipine—Tension—Doxorubicin—hematologic cancer	3.18e-05	0.000166	CcSEcCtD
Felodipine—Rash—Prednisolone—hematologic cancer	3.17e-05	0.000166	CcSEcCtD
Felodipine—Dermatitis—Prednisolone—hematologic cancer	3.17e-05	0.000166	CcSEcCtD
Felodipine—Fatigue—Prednisone—hematologic cancer	3.15e-05	0.000165	CcSEcCtD
Felodipine—Headache—Prednisolone—hematologic cancer	3.15e-05	0.000165	CcSEcCtD
Felodipine—Nervousness—Doxorubicin—hematologic cancer	3.15e-05	0.000165	CcSEcCtD
Felodipine—Vertigo—Epirubicin—hematologic cancer	3.15e-05	0.000165	CcSEcCtD
Felodipine—Syncope—Epirubicin—hematologic cancer	3.14e-05	0.000164	CcSEcCtD
Felodipine—Back pain—Doxorubicin—hematologic cancer	3.13e-05	0.000164	CcSEcCtD
Felodipine—Constipation—Prednisone—hematologic cancer	3.12e-05	0.000164	CcSEcCtD
Felodipine—Muscle spasms—Doxorubicin—hematologic cancer	3.12e-05	0.000163	CcSEcCtD
Felodipine—Palpitations—Epirubicin—hematologic cancer	3.09e-05	0.000162	CcSEcCtD
Felodipine—Confusional state—Methotrexate—hematologic cancer	3.08e-05	0.000161	CcSEcCtD
Felodipine—Loss of consciousness—Epirubicin—hematologic cancer	3.08e-05	0.000161	CcSEcCtD
Felodipine—Dizziness—Triamcinolone—hematologic cancer	3.06e-05	0.00016	CcSEcCtD
Felodipine—Cough—Epirubicin—hematologic cancer	3.06e-05	0.00016	CcSEcCtD
Felodipine—Nausea—Etoposide—hematologic cancer	3.03e-05	0.000159	CcSEcCtD
Felodipine—Feeling abnormal—Prednisone—hematologic cancer	3.01e-05	0.000158	CcSEcCtD
Felodipine—Asthenia—Betamethasone—hematologic cancer	3.01e-05	0.000158	CcSEcCtD
Felodipine—Asthenia—Dexamethasone—hematologic cancer	3.01e-05	0.000158	CcSEcCtD
Felodipine—Anaemia—Doxorubicin—hematologic cancer	2.99e-05	0.000157	CcSEcCtD
Felodipine—Gastrointestinal pain—Prednisone—hematologic cancer	2.99e-05	0.000156	CcSEcCtD
Felodipine—Nausea—Prednisolone—hematologic cancer	2.99e-05	0.000156	CcSEcCtD
Felodipine—Chest pain—Epirubicin—hematologic cancer	2.98e-05	0.000156	CcSEcCtD
Felodipine—Arthralgia—Epirubicin—hematologic cancer	2.98e-05	0.000156	CcSEcCtD
Felodipine—Myalgia—Epirubicin—hematologic cancer	2.98e-05	0.000156	CcSEcCtD
Felodipine—Pruritus—Betamethasone—hematologic cancer	2.97e-05	0.000155	CcSEcCtD
Felodipine—Pruritus—Dexamethasone—hematologic cancer	2.97e-05	0.000155	CcSEcCtD
Felodipine—Vomiting—Triamcinolone—hematologic cancer	2.94e-05	0.000154	CcSEcCtD
Felodipine—Rash—Triamcinolone—hematologic cancer	2.92e-05	0.000153	CcSEcCtD
Felodipine—Dry mouth—Epirubicin—hematologic cancer	2.92e-05	0.000153	CcSEcCtD
Felodipine—Dermatitis—Triamcinolone—hematologic cancer	2.91e-05	0.000152	CcSEcCtD
Felodipine—Vertigo—Doxorubicin—hematologic cancer	2.91e-05	0.000152	CcSEcCtD
Felodipine—Syncope—Doxorubicin—hematologic cancer	2.91e-05	0.000152	CcSEcCtD
Felodipine—Urticaria—Prednisone—hematologic cancer	2.9e-05	0.000152	CcSEcCtD
Felodipine—Headache—Triamcinolone—hematologic cancer	2.9e-05	0.000152	CcSEcCtD
Felodipine—Abdominal pain—Prednisone—hematologic cancer	2.89e-05	0.000151	CcSEcCtD
Felodipine—Body temperature increased—Prednisone—hematologic cancer	2.89e-05	0.000151	CcSEcCtD
Felodipine—Confusional state—Epirubicin—hematologic cancer	2.88e-05	0.000151	CcSEcCtD
Felodipine—Diarrhoea—Betamethasone—hematologic cancer	2.87e-05	0.00015	CcSEcCtD
Felodipine—Diarrhoea—Dexamethasone—hematologic cancer	2.87e-05	0.00015	CcSEcCtD
Felodipine—Palpitations—Doxorubicin—hematologic cancer	2.86e-05	0.00015	CcSEcCtD
Felodipine—Loss of consciousness—Doxorubicin—hematologic cancer	2.85e-05	0.000149	CcSEcCtD
Felodipine—Cough—Doxorubicin—hematologic cancer	2.83e-05	0.000148	CcSEcCtD
Felodipine—Shock—Epirubicin—hematologic cancer	2.81e-05	0.000147	CcSEcCtD
Felodipine—Tachycardia—Epirubicin—hematologic cancer	2.79e-05	0.000146	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.78e-05	0.000146	CcSEcCtD
Felodipine—Dizziness—Betamethasone—hematologic cancer	2.77e-05	0.000145	CcSEcCtD
Felodipine—Dizziness—Dexamethasone—hematologic cancer	2.77e-05	0.000145	CcSEcCtD
Felodipine—Insomnia—Methotrexate—hematologic cancer	2.76e-05	0.000145	CcSEcCtD
Felodipine—Arthralgia—Doxorubicin—hematologic cancer	2.76e-05	0.000144	CcSEcCtD
Felodipine—Myalgia—Doxorubicin—hematologic cancer	2.76e-05	0.000144	CcSEcCtD
Felodipine—Chest pain—Doxorubicin—hematologic cancer	2.76e-05	0.000144	CcSEcCtD
Felodipine—Nausea—Triamcinolone—hematologic cancer	2.75e-05	0.000144	CcSEcCtD
Felodipine—Paraesthesia—Methotrexate—hematologic cancer	2.74e-05	0.000144	CcSEcCtD
Felodipine—Dyspnoea—Methotrexate—hematologic cancer	2.72e-05	0.000143	CcSEcCtD
Felodipine—Somnolence—Methotrexate—hematologic cancer	2.71e-05	0.000142	CcSEcCtD
Felodipine—Dry mouth—Doxorubicin—hematologic cancer	2.7e-05	0.000141	CcSEcCtD
Felodipine—Hypersensitivity—Prednisone—hematologic cancer	2.69e-05	0.000141	CcSEcCtD
Felodipine—Dyspepsia—Methotrexate—hematologic cancer	2.69e-05	0.000141	CcSEcCtD
Felodipine—Vomiting—Betamethasone—hematologic cancer	2.67e-05	0.00014	CcSEcCtD
Felodipine—Vomiting—Dexamethasone—hematologic cancer	2.67e-05	0.00014	CcSEcCtD
Felodipine—Confusional state—Doxorubicin—hematologic cancer	2.67e-05	0.00014	CcSEcCtD
Felodipine—Rash—Betamethasone—hematologic cancer	2.65e-05	0.000138	CcSEcCtD
Felodipine—Rash—Dexamethasone—hematologic cancer	2.65e-05	0.000138	CcSEcCtD
Felodipine—Dermatitis—Dexamethasone—hematologic cancer	2.64e-05	0.000138	CcSEcCtD
Felodipine—Dermatitis—Betamethasone—hematologic cancer	2.64e-05	0.000138	CcSEcCtD
Felodipine—Fatigue—Methotrexate—hematologic cancer	2.63e-05	0.000138	CcSEcCtD
Felodipine—Headache—Dexamethasone—hematologic cancer	2.63e-05	0.000138	CcSEcCtD
Felodipine—Headache—Betamethasone—hematologic cancer	2.63e-05	0.000138	CcSEcCtD
Felodipine—Asthenia—Prednisone—hematologic cancer	2.62e-05	0.000137	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.6e-05	0.000136	CcSEcCtD
Felodipine—Shock—Doxorubicin—hematologic cancer	2.6e-05	0.000136	CcSEcCtD
Felodipine—Pruritus—Prednisone—hematologic cancer	2.59e-05	0.000135	CcSEcCtD
Felodipine—Insomnia—Epirubicin—hematologic cancer	2.58e-05	0.000135	CcSEcCtD
Felodipine—Tachycardia—Doxorubicin—hematologic cancer	2.58e-05	0.000135	CcSEcCtD
Felodipine—Paraesthesia—Epirubicin—hematologic cancer	2.57e-05	0.000134	CcSEcCtD
Felodipine—Dyspnoea—Epirubicin—hematologic cancer	2.55e-05	0.000133	CcSEcCtD
Felodipine—Somnolence—Epirubicin—hematologic cancer	2.54e-05	0.000133	CcSEcCtD
Felodipine—Feeling abnormal—Methotrexate—hematologic cancer	2.52e-05	0.000132	CcSEcCtD
Felodipine—Dyspepsia—Epirubicin—hematologic cancer	2.52e-05	0.000132	CcSEcCtD
Felodipine—Diarrhoea—Prednisone—hematologic cancer	2.5e-05	0.000131	CcSEcCtD
Felodipine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.5e-05	0.000131	CcSEcCtD
Felodipine—Nausea—Dexamethasone—hematologic cancer	2.49e-05	0.00013	CcSEcCtD
Felodipine—Nausea—Betamethasone—hematologic cancer	2.49e-05	0.00013	CcSEcCtD
Felodipine—Fatigue—Epirubicin—hematologic cancer	2.46e-05	0.000129	CcSEcCtD
Felodipine—Constipation—Epirubicin—hematologic cancer	2.44e-05	0.000128	CcSEcCtD
Felodipine—Urticaria—Methotrexate—hematologic cancer	2.43e-05	0.000127	CcSEcCtD
Felodipine—Dizziness—Prednisone—hematologic cancer	2.42e-05	0.000126	CcSEcCtD
Felodipine—Abdominal pain—Methotrexate—hematologic cancer	2.41e-05	0.000126	CcSEcCtD
Felodipine—Body temperature increased—Methotrexate—hematologic cancer	2.41e-05	0.000126	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.41e-05	0.000126	CcSEcCtD
Felodipine—Insomnia—Doxorubicin—hematologic cancer	2.39e-05	0.000125	CcSEcCtD
Felodipine—Paraesthesia—Doxorubicin—hematologic cancer	2.37e-05	0.000124	CcSEcCtD
Felodipine—Dyspnoea—Doxorubicin—hematologic cancer	2.36e-05	0.000123	CcSEcCtD
Felodipine—Feeling abnormal—Epirubicin—hematologic cancer	2.36e-05	0.000123	CcSEcCtD
Felodipine—Somnolence—Doxorubicin—hematologic cancer	2.35e-05	0.000123	CcSEcCtD
Felodipine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.34e-05	0.000122	CcSEcCtD
Felodipine—Dyspepsia—Doxorubicin—hematologic cancer	2.33e-05	0.000122	CcSEcCtD
Felodipine—Vomiting—Prednisone—hematologic cancer	2.32e-05	0.000122	CcSEcCtD
Felodipine—Rash—Prednisone—hematologic cancer	2.3e-05	0.000121	CcSEcCtD
Felodipine—Dermatitis—Prednisone—hematologic cancer	2.3e-05	0.00012	CcSEcCtD
Felodipine—Headache—Prednisone—hematologic cancer	2.29e-05	0.00012	CcSEcCtD
Felodipine—Fatigue—Doxorubicin—hematologic cancer	2.28e-05	0.000119	CcSEcCtD
Felodipine—Urticaria—Epirubicin—hematologic cancer	2.27e-05	0.000119	CcSEcCtD
Felodipine—Constipation—Doxorubicin—hematologic cancer	2.26e-05	0.000118	CcSEcCtD
Felodipine—Body temperature increased—Epirubicin—hematologic cancer	2.26e-05	0.000118	CcSEcCtD
Felodipine—Abdominal pain—Epirubicin—hematologic cancer	2.26e-05	0.000118	CcSEcCtD
Felodipine—Hypersensitivity—Methotrexate—hematologic cancer	2.25e-05	0.000118	CcSEcCtD
Felodipine—Asthenia—Methotrexate—hematologic cancer	2.19e-05	0.000115	CcSEcCtD
Felodipine—Feeling abnormal—Doxorubicin—hematologic cancer	2.18e-05	0.000114	CcSEcCtD
Felodipine—Nausea—Prednisone—hematologic cancer	2.17e-05	0.000114	CcSEcCtD
Felodipine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.16e-05	0.000113	CcSEcCtD
Felodipine—Pruritus—Methotrexate—hematologic cancer	2.16e-05	0.000113	CcSEcCtD
Felodipine—Hypersensitivity—Epirubicin—hematologic cancer	2.11e-05	0.00011	CcSEcCtD
Felodipine—Urticaria—Doxorubicin—hematologic cancer	2.1e-05	0.00011	CcSEcCtD
Felodipine—Abdominal pain—Doxorubicin—hematologic cancer	2.09e-05	0.000109	CcSEcCtD
Felodipine—Body temperature increased—Doxorubicin—hematologic cancer	2.09e-05	0.000109	CcSEcCtD
Felodipine—Diarrhoea—Methotrexate—hematologic cancer	2.09e-05	0.000109	CcSEcCtD
Felodipine—Asthenia—Epirubicin—hematologic cancer	2.05e-05	0.000107	CcSEcCtD
Felodipine—Pruritus—Epirubicin—hematologic cancer	2.02e-05	0.000106	CcSEcCtD
Felodipine—Dizziness—Methotrexate—hematologic cancer	2.02e-05	0.000106	CcSEcCtD
Felodipine—Diarrhoea—Epirubicin—hematologic cancer	1.96e-05	0.000102	CcSEcCtD
Felodipine—Hypersensitivity—Doxorubicin—hematologic cancer	1.95e-05	0.000102	CcSEcCtD
Felodipine—Vomiting—Methotrexate—hematologic cancer	1.94e-05	0.000102	CcSEcCtD
Felodipine—Rash—Methotrexate—hematologic cancer	1.93e-05	0.000101	CcSEcCtD
Felodipine—Dermatitis—Methotrexate—hematologic cancer	1.92e-05	0.000101	CcSEcCtD
Felodipine—Headache—Methotrexate—hematologic cancer	1.91e-05	0.0001	CcSEcCtD
Felodipine—Asthenia—Doxorubicin—hematologic cancer	1.9e-05	9.93e-05	CcSEcCtD
Felodipine—Dizziness—Epirubicin—hematologic cancer	1.89e-05	9.89e-05	CcSEcCtD
Felodipine—Pruritus—Doxorubicin—hematologic cancer	1.87e-05	9.79e-05	CcSEcCtD
Felodipine—Vomiting—Epirubicin—hematologic cancer	1.82e-05	9.51e-05	CcSEcCtD
Felodipine—Nausea—Methotrexate—hematologic cancer	1.81e-05	9.5e-05	CcSEcCtD
Felodipine—Diarrhoea—Doxorubicin—hematologic cancer	1.81e-05	9.47e-05	CcSEcCtD
Felodipine—Rash—Epirubicin—hematologic cancer	1.8e-05	9.43e-05	CcSEcCtD
Felodipine—Dermatitis—Epirubicin—hematologic cancer	1.8e-05	9.42e-05	CcSEcCtD
Felodipine—Headache—Epirubicin—hematologic cancer	1.79e-05	9.37e-05	CcSEcCtD
Felodipine—Dizziness—Doxorubicin—hematologic cancer	1.75e-05	9.15e-05	CcSEcCtD
Felodipine—Nausea—Epirubicin—hematologic cancer	1.7e-05	8.89e-05	CcSEcCtD
Felodipine—Vomiting—Doxorubicin—hematologic cancer	1.68e-05	8.8e-05	CcSEcCtD
Felodipine—Rash—Doxorubicin—hematologic cancer	1.67e-05	8.73e-05	CcSEcCtD
Felodipine—Dermatitis—Doxorubicin—hematologic cancer	1.67e-05	8.72e-05	CcSEcCtD
Felodipine—Headache—Doxorubicin—hematologic cancer	1.66e-05	8.67e-05	CcSEcCtD
Felodipine—Nausea—Doxorubicin—hematologic cancer	1.57e-05	8.22e-05	CcSEcCtD
Felodipine—CALM3—Metabolism—PIK3CB—hematologic cancer	1.04e-06	6.3e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—STAT3—hematologic cancer	1.04e-06	6.29e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—PTEN—hematologic cancer	1.04e-06	6.28e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—PTEN—hematologic cancer	1.04e-06	6.28e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.04e-06	6.28e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—NRAS—hematologic cancer	1.03e-06	6.28e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—BRAF—hematologic cancer	1.03e-06	6.25e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—BRAF—hematologic cancer	1.03e-06	6.25e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.03e-06	6.23e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—ALB—hematologic cancer	1.02e-06	6.2e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—EP300—hematologic cancer	1.02e-06	6.2e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CCL2—hematologic cancer	1.02e-06	6.19e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CCL2—hematologic cancer	1.02e-06	6.19e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—IL6R—hematologic cancer	1.02e-06	6.17e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—IL6R—hematologic cancer	1.02e-06	6.17e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CREBBP—hematologic cancer	1.02e-06	6.16e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CREBBP—hematologic cancer	1.02e-06	6.16e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.01e-06	6.1e-06	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PIK3CB—hematologic cancer	1e-06	6.09e-06	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PIK3CB—hematologic cancer	1e-06	6.09e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—STAT3—hematologic cancer	1e-06	6.09e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—STAT3—hematologic cancer	1e-06	6.09e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MAP2K1—hematologic cancer	1e-06	6.08e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—NRAS—hematologic cancer	1e-06	6.07e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—NRAS—hematologic cancer	1e-06	6.07e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CD—hematologic cancer	9.95e-07	6.04e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—SRC—hematologic cancer	9.93e-07	6.03e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—MAPK3—hematologic cancer	9.91e-07	6.01e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—EP300—hematologic cancer	9.88e-07	5.99e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—EP300—hematologic cancer	9.88e-07	5.99e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	9.78e-07	5.93e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—KRAS—hematologic cancer	9.75e-07	5.91e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MAP2K1—hematologic cancer	9.69e-07	5.88e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MAP2K1—hematologic cancer	9.69e-07	5.88e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	9.67e-07	5.87e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CD—hematologic cancer	9.63e-07	5.84e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CD—hematologic cancer	9.63e-07	5.84e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—SRC—hematologic cancer	9.6e-07	5.83e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—SRC—hematologic cancer	9.6e-07	5.83e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	9.59e-07	5.82e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—MAPK3—hematologic cancer	9.58e-07	5.82e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—MAPK3—hematologic cancer	9.58e-07	5.82e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—STAT3—hematologic cancer	9.57e-07	5.81e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—NRAS—hematologic cancer	9.55e-07	5.8e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—FGF2—hematologic cancer	9.53e-07	5.78e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—CREBBP—hematologic cancer	9.51e-07	5.77e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—KRAS—hematologic cancer	9.43e-07	5.72e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—KRAS—hematologic cancer	9.43e-07	5.72e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3R1—hematologic cancer	9.4e-07	5.7e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—GSTP1—hematologic cancer	9.27e-07	5.62e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—STAT3—hematologic cancer	9.26e-07	5.62e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—STAT3—hematologic cancer	9.26e-07	5.62e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—NRAS—hematologic cancer	9.24e-07	5.61e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—NRAS—hematologic cancer	9.24e-07	5.61e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—FGF2—hematologic cancer	9.22e-07	5.59e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—FGF2—hematologic cancer	9.22e-07	5.59e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—MAPK3—hematologic cancer	9.15e-07	5.55e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—JAK2—hematologic cancer	9.14e-07	5.54e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3R1—hematologic cancer	9.09e-07	5.52e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3R1—hematologic cancer	9.09e-07	5.52e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	9.03e-07	5.48e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CD—hematologic cancer	9.02e-07	5.47e-06	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—PTEN—hematologic cancer	9e-07	5.46e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—CREBBP—hematologic cancer	8.97e-07	5.44e-06	CbGpPWpGaD
Felodipine—CALM3—Metabolism—PTEN—hematologic cancer	8.97e-07	5.44e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—PIK3CA—hematologic cancer	8.95e-07	5.43e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MDM2—hematologic cancer	8.92e-07	5.41e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—ALB—hematologic cancer	8.91e-07	5.4e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—KRAS—hematologic cancer	8.9e-07	5.4e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—MYC—hematologic cancer	8.9e-07	5.4e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—CREBBP—hematologic cancer	8.89e-07	5.39e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—TGFB1—hematologic cancer	8.88e-07	5.39e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—MAPK3—hematologic cancer	8.85e-07	5.37e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—MAPK3—hematologic cancer	8.85e-07	5.37e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—JAK2—hematologic cancer	8.84e-07	5.36e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—JAK2—hematologic cancer	8.84e-07	5.36e-06	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—PIK3CA—hematologic cancer	8.79e-07	5.33e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ABCB1—hematologic cancer	8.77e-07	5.32e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CB—hematologic cancer	8.68e-07	5.27e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MTOR—hematologic cancer	8.68e-07	5.27e-06	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PTEN—hematologic cancer	8.67e-07	5.26e-06	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PTEN—hematologic cancer	8.67e-07	5.26e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—PIK3CA—hematologic cancer	8.66e-07	5.26e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—PIK3CA—hematologic cancer	8.66e-07	5.26e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MDM2—hematologic cancer	8.63e-07	5.23e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MDM2—hematologic cancer	8.63e-07	5.23e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—KRAS—hematologic cancer	8.61e-07	5.23e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—KRAS—hematologic cancer	8.61e-07	5.23e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—MYC—hematologic cancer	8.61e-07	5.22e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—MYC—hematologic cancer	8.61e-07	5.22e-06	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—EP300—hematologic cancer	8.59e-07	5.21e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—TGFB1—hematologic cancer	8.59e-07	5.21e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—TGFB1—hematologic cancer	8.59e-07	5.21e-06	CbGpPWpGaD
Felodipine—CALM3—Metabolism—EP300—hematologic cancer	8.55e-07	5.19e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3R1—hematologic cancer	8.52e-07	5.17e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—GSTM1—hematologic cancer	8.51e-07	5.17e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—NCOR1—hematologic cancer	8.51e-07	5.17e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	8.5e-07	5.16e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	8.43e-07	5.11e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MTOR—hematologic cancer	8.39e-07	5.09e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MTOR—hematologic cancer	8.39e-07	5.09e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CB—hematologic cancer	8.39e-07	5.09e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CB—hematologic cancer	8.39e-07	5.09e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—ALB—hematologic cancer	8.39e-07	5.09e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—ALB—hematologic cancer	8.32e-07	5.05e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—HRAS—hematologic cancer	8.28e-07	5.03e-06	CbGpPWpGaD
Felodipine—CALM2—Metabolism—EP300—hematologic cancer	8.27e-07	5.02e-06	CbGpPWpGaD
Felodipine—CALM1—Metabolism—EP300—hematologic cancer	8.27e-07	5.02e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—KRAS—hematologic cancer	8.22e-07	4.99e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—PIK3CA—hematologic cancer	8.18e-07	4.96e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CDKN1B—hematologic cancer	8.14e-07	4.94e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	8.03e-07	4.87e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—HRAS—hematologic cancer	8.01e-07	4.86e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—HRAS—hematologic cancer	8.01e-07	4.86e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CASP3—hematologic cancer	7.98e-07	4.84e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—IL2—hematologic cancer	7.97e-07	4.84e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	7.96e-07	4.83e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—KRAS—hematologic cancer	7.95e-07	4.83e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—KRAS—hematologic cancer	7.95e-07	4.83e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—IL6—hematologic cancer	7.93e-07	4.81e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—PIK3CA—hematologic cancer	7.91e-07	4.8e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—PIK3CA—hematologic cancer	7.91e-07	4.8e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CDKN1B—hematologic cancer	7.88e-07	4.78e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CDKN1B—hematologic cancer	7.88e-07	4.78e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CB—hematologic cancer	7.86e-07	4.77e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PTEN—hematologic cancer	7.8e-07	4.73e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CCND1—hematologic cancer	7.77e-07	4.71e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—JUN—hematologic cancer	7.75e-07	4.7e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CASP3—hematologic cancer	7.72e-07	4.68e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CASP3—hematologic cancer	7.72e-07	4.68e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—IL2—hematologic cancer	7.71e-07	4.68e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—IL2—hematologic cancer	7.71e-07	4.68e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—IL6—hematologic cancer	7.67e-07	4.65e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—IL6—hematologic cancer	7.67e-07	4.65e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—HRAS—hematologic cancer	7.57e-07	4.59e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—PIK3CA—hematologic cancer	7.55e-07	4.58e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—MTHFR—hematologic cancer	7.53e-07	4.57e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CDKN1A—hematologic cancer	7.51e-07	4.56e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CCND1—hematologic cancer	7.51e-07	4.56e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CCND1—hematologic cancer	7.51e-07	4.56e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—JUN—hematologic cancer	7.5e-07	4.55e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—JUN—hematologic cancer	7.5e-07	4.55e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PTEN—hematologic cancer	7.5e-07	4.55e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—EP300—hematologic cancer	7.44e-07	4.51e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	7.41e-07	4.5e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	7.35e-07	4.46e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MAPK8—hematologic cancer	7.33e-07	4.45e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—HRAS—hematologic cancer	7.32e-07	4.44e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—HRAS—hematologic cancer	7.32e-07	4.44e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—AKT1—hematologic cancer	7.31e-07	4.44e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—PIK3CA—hematologic cancer	7.31e-07	4.43e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—PIK3CA—hematologic cancer	7.31e-07	4.43e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CDKN1A—hematologic cancer	7.27e-07	4.41e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CDKN1A—hematologic cancer	7.27e-07	4.41e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PTEN—hematologic cancer	7.25e-07	4.4e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PTEN—hematologic cancer	7.25e-07	4.4e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—IL6—hematologic cancer	7.24e-07	4.4e-06	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—AKT1—hematologic cancer	7.18e-07	4.36e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—EP300—hematologic cancer	7.15e-07	4.34e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MAPK8—hematologic cancer	7.09e-07	4.31e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MAPK8—hematologic cancer	7.09e-07	4.31e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—AKT1—hematologic cancer	7.08e-07	4.29e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—AKT1—hematologic cancer	7.08e-07	4.29e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—IL6—hematologic cancer	7.01e-07	4.25e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—IL6—hematologic cancer	7.01e-07	4.25e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—HRAS—hematologic cancer	6.99e-07	4.24e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—SRC—hematologic cancer	6.95e-07	4.22e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—EP300—hematologic cancer	6.92e-07	4.2e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—EP300—hematologic cancer	6.92e-07	4.2e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PTEN—hematologic cancer	6.79e-07	4.12e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—VEGFA—hematologic cancer	6.77e-07	4.11e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—HRAS—hematologic cancer	6.76e-07	4.1e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—HRAS—hematologic cancer	6.76e-07	4.1e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—SRC—hematologic cancer	6.73e-07	4.08e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—SRC—hematologic cancer	6.73e-07	4.08e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—STAT3—hematologic cancer	6.7e-07	4.07e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—NRAS—hematologic cancer	6.69e-07	4.06e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—IL6—hematologic cancer	6.69e-07	4.06e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—AKT1—hematologic cancer	6.68e-07	4.06e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—VEGFA—hematologic cancer	6.55e-07	3.98e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—VEGFA—hematologic cancer	6.55e-07	3.98e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—STAT3—hematologic cancer	6.49e-07	3.94e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—STAT3—hematologic cancer	6.49e-07	3.94e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—EP300—hematologic cancer	6.48e-07	3.93e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—NRAS—hematologic cancer	6.47e-07	3.93e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—NRAS—hematologic cancer	6.47e-07	3.93e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—IL6—hematologic cancer	6.47e-07	3.93e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—IL6—hematologic cancer	6.47e-07	3.93e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—AKT1—hematologic cancer	6.46e-07	3.92e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—AKT1—hematologic cancer	6.46e-07	3.92e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MAPK3—hematologic cancer	6.41e-07	3.89e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PTEN—hematologic cancer	6.4e-07	3.89e-06	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	6.35e-07	3.86e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PTEN—hematologic cancer	6.35e-07	3.85e-06	CbGpPWpGaD
Felodipine—CALM3—Metabolism—PIK3CA—hematologic cancer	6.33e-07	3.84e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	6.32e-07	3.84e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MYC—hematologic cancer	6.23e-07	3.78e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—TGFB1—hematologic cancer	6.22e-07	3.77e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MAPK3—hematologic cancer	6.2e-07	3.76e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MAPK3—hematologic cancer	6.2e-07	3.76e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—AKT1—hematologic cancer	6.17e-07	3.74e-06	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PIK3CA—hematologic cancer	6.12e-07	3.71e-06	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PIK3CA—hematologic cancer	6.12e-07	3.71e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—EP300—hematologic cancer	6.11e-07	3.71e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—EP300—hematologic cancer	6.05e-07	3.67e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MYC—hematologic cancer	6.03e-07	3.66e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MYC—hematologic cancer	6.03e-07	3.66e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—TGFB1—hematologic cancer	6.01e-07	3.65e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—TGFB1—hematologic cancer	6.01e-07	3.65e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—AKT1—hematologic cancer	5.97e-07	3.62e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—AKT1—hematologic cancer	5.97e-07	3.62e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CREBBP—hematologic cancer	5.86e-07	3.56e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—KRAS—hematologic cancer	5.76e-07	3.49e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—KRAS—hematologic cancer	5.57e-07	3.38e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—KRAS—hematologic cancer	5.57e-07	3.38e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	5.56e-07	3.37e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	5.5e-07	3.34e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ALB—hematologic cancer	5.49e-07	3.33e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CA—hematologic cancer	5.29e-07	3.21e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	5.25e-07	3.19e-06	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—AKT1—hematologic cancer	5.19e-07	3.15e-06	CbGpPWpGaD
Felodipine—CALM3—Metabolism—AKT1—hematologic cancer	5.17e-07	3.14e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—TP53—hematologic cancer	5.12e-07	3.11e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CA—hematologic cancer	5.12e-07	3.1e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CA—hematologic cancer	5.12e-07	3.1e-06	CbGpPWpGaD
Felodipine—CALM2—Metabolism—AKT1—hematologic cancer	5e-07	3.03e-06	CbGpPWpGaD
Felodipine—CALM1—Metabolism—AKT1—hematologic cancer	5e-07	3.03e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—TP53—hematologic cancer	4.95e-07	3e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—TP53—hematologic cancer	4.95e-07	3e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—HRAS—hematologic cancer	4.89e-07	2.97e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	4.84e-07	2.94e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CA—hematologic cancer	4.79e-07	2.91e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—HRAS—hematologic cancer	4.73e-07	2.87e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—HRAS—hematologic cancer	4.73e-07	2.87e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—IL6—hematologic cancer	4.68e-07	2.84e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—IL6—hematologic cancer	4.53e-07	2.75e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—IL6—hematologic cancer	4.53e-07	2.75e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	4.52e-07	2.74e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—AKT1—hematologic cancer	4.49e-07	2.73e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	4.48e-07	2.72e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—AKT1—hematologic cancer	4.32e-07	2.62e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PTEN—hematologic cancer	4.19e-07	2.54e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—AKT1—hematologic cancer	4.18e-07	2.54e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—AKT1—hematologic cancer	4.18e-07	2.54e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—EP300—hematologic cancer	3.99e-07	2.42e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—AKT1—hematologic cancer	3.92e-07	2.38e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—AKT1—hematologic cancer	3.69e-07	2.24e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—AKT1—hematologic cancer	3.66e-07	2.22e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.95e-07	1.79e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—AKT1—hematologic cancer	2.41e-07	1.46e-06	CbGpPWpGaD
